131 related articles for article (PubMed ID: 35737153)
21. Clear Cell Variant of a Follicular Thyroid Tumor With Uncertain Malignant Potential: A Case Report.
Juhlin CC; Bränström R; Shabo I; Höög A
Int J Surg Pathol; 2019 May; 27(3):290-293. PubMed ID: 30370813
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
23. QPRT: a potential marker for follicular thyroid carcinoma including minimal invasive variant; a gene expression, RNA and immunohistochemical study.
Hinsch N; Frank M; Döring C; Vorländer C; Hansmann ML
BMC Cancer; 2009 Mar; 9():93. PubMed ID: 19321014
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
25. Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours.
Wojtas B; Pfeifer A; Oczko-Wojciechowska M; Krajewska J; Czarniecka A; Kukulska A; Eszlinger M; Musholt T; Stokowy T; Swierniak M; Stobiecka E; Chmielik E; Rusinek D; Tyszkiewicz T; Halczok M; Hauptmann S; Lange D; Jarzab M; Paschke R; Jarzab B
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28574441
[TBL] [Abstract][Full Text] [Related]
26. Follicular lesions of the thyroid.
Mathur A; Olson MT; Zeiger MA
Surg Clin North Am; 2014 Jun; 94(3):499-513. PubMed ID: 24857573
[TBL] [Abstract][Full Text] [Related]
27. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma.
Umbricht CB; Saji M; Westra WH; Udelsman R; Zeiger MA; Sukumar S
Cancer Res; 1997 Jun; 57(11):2144-7. PubMed ID: 9187112
[TBL] [Abstract][Full Text] [Related]
28. Spectroscopic identification of benign (follicular adenoma) and cancerous lesions (follicular thyroid carcinoma) in thyroid tissues.
Depciuch J; Stanek-Widera A; Skrzypiec D; Lange D; Biskup-Frużyńska M; Kiper K; Stanek-Tarkowska J; Kula M; Cebulski J
J Pharm Biomed Anal; 2019 Jun; 170():321-326. PubMed ID: 30954022
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive DNA Methylation Profiling Identifies Novel Diagnostic Biomarkers for Thyroid Cancer.
Park JL; Jeon S; Seo EH; Bae DH; Jeong YM; Kim Y; Bae JS; Kim SK; Jung CK; Kim YS
Thyroid; 2020 Feb; 30(2):192-203. PubMed ID: 31797753
[No Abstract] [Full Text] [Related]
31. The demise of follicular carcinoma of the thyroid gland.
LiVolsi VA; Asa SL
Thyroid; 1994; 4(2):233-6. PubMed ID: 7920009
[TBL] [Abstract][Full Text] [Related]
32. [Follicular thyroid tumor as a diagnostic and therapeutic problem].
Król R; Heitzman M; Pawlicki J; Ziaja J; Cierpka L
Postepy Hig Med Dosw (Online); 2004; 58():490-4. PubMed ID: 15765010
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Pool C; Walter V; Bann D; Goldenberg D; Broach J; Hennessy M; Cottrill E; Washburn E; Williams N; Crist H; Imamura Y; Warrick JI
Virchows Arch; 2019 Mar; 474(3):341-351. PubMed ID: 30645670
[TBL] [Abstract][Full Text] [Related]
34. Galectin-1 is a diagnostic marker involved in thyroid cancer progression.
Arcolia V; Journe F; Wattier A; Leteurtre E; Renaud F; Gabius HJ; Remmelink M; Decaestecker C; Rodriguez A; Boutry S; Laurent S; Saussez S
Int J Oncol; 2017 Sep; 51(3):760-770. PubMed ID: 28677745
[TBL] [Abstract][Full Text] [Related]
35. Artificial neural network model to distinguish follicular adenoma from follicular carcinoma on fine needle aspiration of thyroid.
Savala R; Dey P; Gupta N
Diagn Cytopathol; 2018 Mar; 46(3):244-249. PubMed ID: 29266871
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
World J Surg; 2006 May; 30(5):767-74. PubMed ID: 16547620
[TBL] [Abstract][Full Text] [Related]
37. Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours.
Sheu SY; Grabellus F; Schwertheim S; Worm K; Broecker-Preuss M; Schmid KW
Br J Cancer; 2010 Jan; 102(2):376-82. PubMed ID: 20029416
[TBL] [Abstract][Full Text] [Related]
38. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas.
Pallante P; Visone R; Croce CM; Fusco A
Endocr Relat Cancer; 2010 Mar; 17(1):F91-104. PubMed ID: 19942715
[TBL] [Abstract][Full Text] [Related]
39. Is atypical follicular adenoma of the thyroid a preinvasive malignancy?
Tzen CY; Huang YW; Fu YS
Hum Pathol; 2003 Jul; 34(7):666-9. PubMed ID: 12874762
[TBL] [Abstract][Full Text] [Related]
40. Selection and validation of miRNAs as normalizers for profiling expression of microRNAs isolated from thyroid fine needle aspiration smears.
Titov SE; Demenkov PS; Ivanov MK; Malakhina ES; Poloz TL; Tsivlikova EV; Ganzha MS; Shevchenko SP; Gulyaeva LF; Kolesnikov NN
Oncol Rep; 2016 Nov; 36(5):2501-2510. PubMed ID: 27666315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]